AstraZeneca has requested emergency use authorisation from U.S. regulators for its new treatment ...

The mRNA vaccine from Pfizer (PFE.N) and BioNTech (22UAy.DE) may be less effective than Moderna's...

Johnson & Johnson (JNJ.N) said on Monday it was still in talks with the Indian government over it...

Demonstrated strong neutralizing antibody activity against the Delta (B.1.617.2) variant   Persis...

Using different brands of COVID vaccines for first and second doses appears to give good protecti...

India's Serum Institute is seeking emergency authorisation in the European Union for its Covishie...

A study in 5.8 million children has found a higher incidence of stroke four decades later in thos...

India has accelerated its coronavirus vaccine production amid a deadly second COVID wave, BBC rep...

More than 350 Indonesian doctors have contracted COVID-19 despite being vaccinated with Sinovac a...

The U.S. Food and Drug Administration is taking its biggest risk yet with a strategy that allows ...

Europe's drug regulator EMA has recommended extending the storage time for the Pfizer-BioNTech Co...

 U.S. federal health agencies on Tuesday recommended pausing the use of Johnson & Johnson’s COVID...

India has approved the use of Russia’s “Sputnik V” vaccine against COVID-19 based on strong immun...

India’s Cadila Healthcare Ltd has sought approval from local regulators to use a Hepatitis C drug...

 Indian biotech firm Panacea Biotec Ltd has agreed to produce 100 million doses of Russia’s Sputn...

People under 60-years old who have had a first shot of AstraZeneca’s COVID-19 vaccine should rece...